Works matching AU McDonough, Jessica
Results: 9
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder.
- Published in:
- CNS Drugs, 2023, v. 37, n. 4, p. 337, doi. 10.1007/s40263-023-00996-8
- By:
- Publication type:
- Article
Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study.
- Published in:
- Current Medical Research & Opinion, 2023, v. 39, n. 7, p. 1021, doi. 10.1080/03007995.2023.2219155
- By:
- Publication type:
- Article
Centanafadine Sustained Release in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: Secondary Outcomes From a Phase 2a Study.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
52-Week Open-Label Safety and Tolerability Trial of Centanafadine Sustained Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Centanafadine Sustained Release Is Efficacious in Patients with Adult ADHD, Regardless of Their Treatment History.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Centanafadine Sustained Release Is Efficacious in the Treatment of Adult ADHD Across Disease Severities.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison.
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 1409, doi. 10.2147/NDT.S412357
- By:
- Publication type:
- Article
Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii ®) in people with bipolar I disorder: a Plain Language Summary of Publication.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2024, p. 1, doi. 10.1177/20451253241278830
- By:
- Publication type:
- Article
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2024, p. 1, doi. 10.1177/20451253241286319
- By:
- Publication type:
- Article